Trial met both co-primary endpoints of mean change from baseline in BCVA letter score and mean change from baseline CST with statistical ...
Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing novel, allogeneic, "off the shelf", cell therapies for serious medical conditions, today provided an update on COR1, ...
Not to mention paying out of pocket if you don't have vision insurance. Eyebot, an AI-powered health tech company, wants to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results